Zometa Side Effects Increase Risk of Osteonecrosis of the Jaw: Study
A new study suggests frequent Zometa injections increase the risk of jawbone death for some cancer patients.
A new study suggests frequent Zometa injections increase the risk of jawbone death for some cancer patients.
A federal judge has ordered parties involved in Fosamax femur fracture lawsuits into mediation to hopefully reach a Fosamax fracture settlement.
A new study provides new evidence linking the bone drug Fosamax to an increased risk of jaw bone death, involving a rare condition known as osteonecrosis of the jaw.
The judge presiding over all Fosamax femur fracture lawsuits has granted summary judgment in a lawsuit over the 2010 warning update, which could put hundreds of additional lawsuits in jeopardy…
Merck has agreed to settle federal Fosamax jaw decay claims for $27.7 million, but only if all plaintiffs agree to join in.
A new study finds a strong correlation between Fosamax side effects and claims of femur and jaw damage in FDA reports.
Merck may face a hundreds Fosamax trials nationwide, as the federal MDL over jaw injuries is wound down over the next six months.
A federal judge has rejected an attempt by Merck to whittle down the number of Fosamax lawsuits it could end up facing in courts nationwide after settlement talks fell through.
After more than seven years of litigating Fosamax lawsuits, there is no end in sight for Merck, who may soon trials nationwide.
A New Jersey jury returned a defense verdict this week in a trial over claims that the bone-strengthening drug Zometa caused a woman’s jaw bone to decay.